NAMP
XBI icon

NorthStar Asset Management (Pennsylvania)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Hold
5,100
– – 0.14% 84
2026
Q1 		$651K Hold
5,100
– – 0.15% 77
2025
Q4 		$622K Hold
5,100
– – 0.13% 81
2025
Q3 		$511K Sell
5,100
-1,000
-16% -$90.1K 0.11% 90
2025
Q2 		$506K Sell
6,100
-225
-4% -$17.9K 0.12% 93
2025
Q1 		$513K Sell
6,325
-975
-13% -$87.1K 0.12% 86
2024
Q4 		$657K Hold
7,300
– – 0.15% 78
2024
Q3 		$721K Sell
7,300
-525
-7% -$51.6K 0.17% 79
2024
Q2 		$725K Sell
7,825
-50
-0.6% -$4.48K 0.18% 75
2024
Q1 		$747K Sell
7,875
-100
-1% -$9.28K 0.18% 74
2023
Q4 		$712K Sell
7,975
-700
-8% -$52K 0.19% 79
2023
Q3 		$633K Sell
8,675
-245
-3% -$19.6K 0.18% 79
2023
Q2 		$742K Sell
8,920
-300
-3% -$25.1K 0.2% 75
2023
Q1 		$703K Sell
9,220
-1,500
-14% -$124K 0.21% 75
2022
Q4 		$890K Sell
10,720
-150
-1% -$12.1K 0.28% 63
2022
Q3 		$862K Sell
10,870
-30
-0.3% -$2.53K 0.29% 65
2022
Q2 		$809K Sell
10,900
-1,600
-13% -$120K 0.25% 70
2022
Q1 		$1.12M Sell
12,500
-863
-6% -$79.7K 0.29% 68
2021
Q4 		$1.5M Hold
13,363
– – 0.35% 59
2021
Q3 		$1.68M Hold
13,363
– – 0.44% 57
2021
Q2 		$1.81M Buy
13,363
+17
+0.1% +$2.23K 0.48% 54
2021
Q1 		$1.81M Sell
13,346
-29
-0.2% -$4.34K 0.52% 52
2020
Q4 		$1.88M Buy
13,375
+300
+2% +$38.4K 0.54% 44
2020
Q3 		$1.46M Buy
13,075
+1,125
+9% +$126K 0.47% 52
2020
Q2 		$1.34M Sell
11,950
-40
-0.3% -$3.94K 0.48% 46
2020
Q1 		$929K Buy
11,990
+125
+1% +$11.1K 0.43% 54
2019
Q4 		$1.13M Sell
11,865
-350
-3% -$30.3K 0.42% 57
2019
Q3 		$931K Buy
12,215
+90
+0.7% +$7.48K 0.36% 63
2019
Q2 		$1.06M Sell
12,125
-300
-2% -$25.6K 0.42% 57
2019
Q1 		$1.13M Sell
12,425
-975
-7% -$82.9K 0.46% 54
2018
Q4 		$962K Buy
+13,400
New +$1.08M 0.45% 58
2018
Q3 		– Sell
-2,505
Closed -$238K – 117
2018
Q2 		$238K Hold
2,505
– – 0.1% 101
2018
Q1 		$220K Hold
2,505
– – 0.09% 103
2017
Q4 		$213K Hold
2,505
– – 0.09% 102
2017
Q3 		$217K Buy
+2,505
New +$201K 0.1% 101
2016
Q4 		– Sell
-24,145
Closed -$1.6M – 118
2016
Q3 		$1.6M Sell
24,145
-14,325
-37% -$886K 0.67% 44
2016
Q2 		$2.08M Buy
38,470
+500
+1% +$27.4K 0.87% 38
2016
Q1 		$1.96M Buy
37,970
+4,285
+13% +$223K 0.84% 38
2015
Q4 		$2.36M Sell
33,685
-6,380
-16% -$435K 1.01% 32
2015
Q3 		$2.49M Buy
+40,065
New +$3.16M 1.12% 25

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s XBI Position: Q2 2026 in Review

NorthStar Asset Management (Pennsylvania) held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 5,100 shares worth $767K. The position accounts for 0.14% of the portfolio, ranked #84.

NorthStar Asset Management (Pennsylvania) first reported a position in XBI in Q3 2015 and has held it in 40 quarters since. The position peaked at $2.49M in Q3 2015. 282 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • NorthStar Asset Management (Pennsylvania) held 5,100 shares of State Street SPDR S&P Biotech ETF worth $767K as of Q2 2026.
  • NorthStar Asset Management (Pennsylvania) left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.14% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q2 2026, its #84 holding.
  • NorthStar Asset Management (Pennsylvania) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 40 quarters since.
  • NorthStar Asset Management (Pennsylvania)'s State Street SPDR S&P Biotech ETF position peaked at $2.49M in Q3 2015.
  • 282 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2026, filed 27 Jul 2026.